These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 11921430)

  • 41. Non-invasive glucose monitoring technology in diabetes management: a review.
    Vashist SK
    Anal Chim Acta; 2012 Oct; 750():16-27. PubMed ID: 23062426
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Study of principles of non-invasive glucose monitoring and instruments with the methods].
    Ji Z; Qin Z; Cheng X; Peng C
    Sheng Wu Yi Xue Gong Cheng Xue Za Zhi; 2010 Feb; 27(1):222-6. PubMed ID: 20337059
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effect of interstitial fluid pH on transdermal glucose extraction by reverse iontophoresis.
    Zhu W; Yu H; Pu Z; Guo Z; Zheng H; Li C; Zhang X; Li J; Li D
    Biosens Bioelectron; 2023 Sep; 235():115406. PubMed ID: 37210841
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Device and Method for Noninvasive Glucose Assessment.
    Segman YJ
    J Diabetes Sci Technol; 2018 Nov; 12(6):1159-1168. PubMed ID: 29575926
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overview of a novel sensor for continuous glucose monitoring.
    Schmelzeisen-Redeker G; Staib A; Strasser M; Müller U; Schoemaker M
    J Diabetes Sci Technol; 2013 Jul; 7(4):808-14. PubMed ID: 23911161
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The Continuous Glucose Monitoring System during pregnancy of women with type 1 diabetes mellitus: accuracy assessment.
    Kerssen A; de Valk HW; Visser GH
    Diabetes Technol Ther; 2004 Oct; 6(5):645-51. PubMed ID: 15628818
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Continuous glucose sensing: future technology developments.
    Brauker J
    Diabetes Technol Ther; 2009 Jun; 11 Suppl 1():S25-36. PubMed ID: 19469675
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Model of glucose sensor error components: identification and assessment for new Dexcom G4 generation devices.
    Facchinetti A; Del Favero S; Sparacino G; Cobelli C
    Med Biol Eng Comput; 2015 Dec; 53(12):1259-69. PubMed ID: 25416850
    [TBL] [Abstract][Full Text] [Related]  

  • 49. First application of a transcutaneous optical single-port glucose monitoring device in patients with type 1 diabetes mellitus.
    Rumpler M; Mader JK; Fischer JP; Thar R; Granger JM; Deliane F; Klimant I; Aberer F; Sinner F; Pieber TR; Hajnsek M
    Biosens Bioelectron; 2017 Feb; 88():240-248. PubMed ID: 27554063
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Reverse iontophoresis for non-invasive transdermal monitoring.
    Leboulanger B; Guy RH; Delgado-Charro MB
    Physiol Meas; 2004 Jun; 25(3):R35-50. PubMed ID: 15253111
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Towards smart tattoos: implantable biosensors for continuous glucose monitoring.
    Heo YJ; Takeuchi S
    Adv Healthc Mater; 2013 Jan; 2(1):43-56. PubMed ID: 23184404
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Micro interstitial fluid extraction and detection device integrated with the optimal extraction conditions for noninvasive glucose monitoring.
    Tianyi S; Yulong Z; Yanzhen J; Chen CJ; Liu JT
    Biosens Bioelectron; 2023 Oct; 237():115515. PubMed ID: 37481866
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of time lags and other sources of error of the DexCom SEVEN continuous glucose monitor.
    Kamath A; Mahalingam A; Brauker J
    Diabetes Technol Ther; 2009 Nov; 11(11):689-95. PubMed ID: 19905884
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Performance characterization of an abiotic and fluorescent-based continuous glucose monitoring system in patients with type 1 diabetes.
    Mortellaro M; DeHennis A
    Biosens Bioelectron; 2014 Nov; 61():227-31. PubMed ID: 24906080
    [TBL] [Abstract][Full Text] [Related]  

  • 55. FDA panel approves Cygnus's noninvasive GlucoWatch.
    Sage BH
    Diabetes Technol Ther; 2000; 2(1):115-6. PubMed ID: 11467309
    [No Abstract]   [Full Text] [Related]  

  • 56. A lightweight measuring device for the continuous in vivo monitoring of glucose by means of ultraslow microdialysis in combination with a miniaturised flow-through biosensor.
    Rhemrev-Boom RM; Tiessen RG; Jonker AA; Venema K; Vadgama P; Korf J
    Clin Chim Acta; 2002 Feb; 316(1-2):1-10. PubMed ID: 11750268
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Accuracy of the EasyTouch blood glucose self-monitoring system: a study of 516 cases.
    Dai KS; Tai DY; Ho P; Chen CC; Peng WC; Chen ST; Hsu CC; Liu YP; Hsieh HC; Yang CC; Tsai MC; Mao SJ
    Clin Chim Acta; 2004 Nov; 349(1-2):135-41. PubMed ID: 15469866
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Glucowatch Biographer: a noninvasive glucose monitoring device.
    Med Lett Drugs Ther; 2001 May; 43(1104):42. PubMed ID: 11353926
    [No Abstract]   [Full Text] [Related]  

  • 59. Enzyme-Based Glucose Sensor: From Invasive to Wearable Device.
    Lee H; Hong YJ; Baik S; Hyeon T; Kim DH
    Adv Healthc Mater; 2018 Apr; 7(8):e1701150. PubMed ID: 29334198
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Clinical accuracy of a continuous glucose monitoring system with an advanced algorithm.
    Bailey TS; Chang A; Christiansen M
    J Diabetes Sci Technol; 2015 Mar; 9(2):209-14. PubMed ID: 25370149
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.